Reply to comment on “The risk assessment of uveitis after COVID‐19 diagnosis by Wu et al. 2024”-Reference-Cited by-同舟云学术

Reply to comment on “The risk assessment of uveitis after COVID‐19 diagnosis by Wu et al. 2024”

Published:2024-04-25 Issue:5 Volume:96 Page:
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Hsu Alan Y.¹^ORCID,Lin Chun‐Ju¹²³^ORCID,Hsia Ning‐Yi¹²³,Wang Yu‐Hsun⁴,Li Jing‐Xing⁴⁵⁶^ORCID,Chen Huan‐Sheng⁷,Wei James Cheng‐Chung⁴⁸⁹¹⁰¹¹,Tsai Yi‐Yu¹²³

Affiliation:

1. Department of Ophthalmology China Medical University Hospital, China Medical University Taichung Taiwan

2. School of Medicine, College of Medicine China Medical University Taichung Taiwan

3. Department of Optometry Asia University Taichung Taiwan

4. Department of Medical Research Chung Shan Medical University Hospital Taichung Taiwan

5. Department of General Medicine China Medical University Hospital Taichung Taiwan

6. Institute of Clinical Laboratory Sciences and Medical Biotechnology National Taiwan University Taipei Taiwan

7. An‐Shin Dialysis Center, NephroCare Ltd., Fresenius Medical Care Taichung Taiwan

8. Institute of Medicine Chung Shan Medical University Taichung Taiwan

9. Department of Allergy, Immunology & Rheumatology Chung Shan Medical University Hospital Taichung Taiwan

10. Institute of Integrated Medicine China Medical University Taichung Taiwan

11. Department of Nursing Chung Shan Medical University Taichung Taiwan

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.29636

Reference3 articles.

1. Comment on “The risk assessment of uveitis after COVID‐19 diagnosis”

2. The risk assessment of uveitis after COVID‐19 diagnosis: A multicenter population‐based study

3. Sensitivity of Reverse Transcription Polymerase Chain Reaction Tests for Severe Acute Respiratory Syndrome Coronavirus 2 Through Time